Piergiorgio Natali (Mediterranean Task force for Cancer Control) discusses the importance of improving functional foods as a strategy to support health, particularly during aging.
A youthful gut microbiota can improve the regenerative function of aged intestinal stem cells.
VOS, an FDA-approved oral microbiota therapy, has been shown to reduce infection risk compared to traditional fecal transplants.
Gut microbes can influence cancer outcomes by regulating nutrient availability and uptake in immune cells.
Lorenza Putignani, Pediatric Hospital Bambino Gesù, Italy, discusses translational research in the microbiome field.
Effective treatment of IBD requires an approach combining tailored donors, microbiota analysis, and diet.
The findings reveal a gut-testis interplay that may explain why low oxygen environments reduce male fertility at high altitudes.
Marika Falcone of San Raffaele Hospital in Milan discusses the growing evidence linking the gut microbiome to extra-intestinal autoimmune diseases.
The oral microbiome is not a dental concern. It is a medical frontier.
Segmented filamentous bacteria, or SFB, protect mice from these deadly infections by reprogramming specific immune cells in the lungs.
